Adding to the pressure is that CVS Health has retained coverage of Zepbound's arch rival Wegovy (semaglutide), sold by Novo ...

GSK has highlighted approval of Nucala in COPD as one of its top 2025 priorities, adding to its established medicines for the ...

"DHE plays a unique clinical role in the acute treatment of migraine, providing patients long-lasting effects and the unique ...

According to the WSJ, the universal vaccine project is being pioneered by two recently appointed senior scientists in the NIH ...

Informed consent is a foundational element of every clinical trial. Yet, the traditional paper-based process has long been ...

But international agreements are notoriously difficult to enforce, and pharma companies and patient advocates who were ...

Despite these benefits, biosimilar medicines remain under-recognised and underused in many markets. Real-world uptake often ...

According to NICE's Early Value Assessment (EVA) guidance on the technology, automated use of DERM "could result in more ...

The NIH – which is the world's biggest funder of biomedical research – issued a new policy document yesterday that indicates ...

AstraZeneca's three-drug inhaler Breztri Aerosphere has shown efficacy for uncontrolled asthma in a pair of phase 3 trials ...

Using advanced imaging technologies as a means to enhance diagnostic accuracy was also of interest. Many HCPs pointed to the ...

The application has been submitted by the capital investment arm of insurance company Aviva and mixed-use developer Socius, ...